Clinical Trial Update: A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the clinical efficacy of the fixed-dose combination of emtricitabine, tenofovir, and nevirapine in HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• emtricitabine, tenofovir, and nevirapine fixed-dose combination

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: HIV | Phase 4 | Status: COMPLETED | Results posted: 2017-11-14